Senegal

in page functions
Total population (2012)13,107,945
Birth cohort (2012)475,941
Surviving Infants (surviving to 1 year per year, 2012)451,971
Infant mortality rate (deaths < 1 year per 1000 births, 2011)46.70/1000
Child mortality rate (deaths < 5 years per 1000 births, 2011)64.80/1000
World Bank Index, IDA (2012)3.68
Gross Nation Income (per capita US$, 2011)1,070
Co-financing status (2012)Intermediate
No. of districts/territories (2011)75

GAVI support for Senegal

Type of support

Approvals

2001-2016 (US$)
(30 Apr 2013)

Commitments

2001-2016 (US$)
(30 Apr 2013)

Disbursements

2001-2012 (US$)
(30 Apr 2013)

% Disbursed

(30 Apr 2013)
200220032004200520062007200820092010201120122013201420152016
Health System Strengthening (HSS)$3,585,500$3,585,500$3,585,500100%
HepB mono (NVS)$588,743$588,743$588,743100%
Immunisation Services Support (ISS)$2,605,740$2,605,740$2,605,740100%
Injection Safety Support (INS)$619,474$619,474$619,474100%
Measles-Rubella (NVS)$4,932,000$4,932,000$4,751,99796%
Meningitis A - campaign (NVS)$3,054,000$3,054,000$2,768,71591%
Meningitis A - operational costs (OPC)$2,567,107$2,567,107$2,567,107100%
MR - Operational costs (OPC)$4,158,500$4,158,500
Penta (NVS)$36,598,878$42,588,878$37,202,339102%
Pneumo (NVS)$2,780,000$25,178,000
Vaccine Introduction Grant$914,000$914,000$100,00011%
Total$62,403,942$90,791,942$54,789,615

Red line on table indicates duration of support based on commitments.
Commitments: Multi-year programme budgets endorsed in principle by the GAVI Board. These become financial commitments upon approval each year for the following calendar year.
Approvals: Total Approved for funding (IRC Reviewed)

Download data for commitments & disbursements in XLS format

Senegal DTP3 / immunisation coverage

DTP3 - WHO/UNICEF estimates (2011)

Grade of Confidence
83%

**
DTP3 - Official country estimates (2011)83%
M:F sex ratio at birth (2012)1.03
Household survey: DTP3 coverage for male (2009)84.30%
Household survey: DTP3 coverage for female (2009)80.70%
Household survey: Last DTP3 survey (2009)83%
% districts achieving > 80% DTP3 coverage (2010)5%
% districts achieving < 50% DTP3 coverage (2010)62%
MCV WHO/UNICEF estimates (2011)82%
Polio WHO/UNICEF estimates (2011)73%

Breakdown of support

Non-vaccine supportVaccine support
17% 83%
$9,477,821 $45,311,794

Data refers to disbursed values, date as per above chart

Move mouse over graph for details

News and updates relating to Senegal

19 May 2013

WHO World Health Assembly

Guide to immunisation topics on 2013 World Health Assembly agenda

Thousands of health experts, Member State delegations and international organisations will gather in Geneva from 20-28 May for the WHO’s 66th World Health Assembly. In this preview, we highlight topics on the agenda that will help shape the future of global immunisation.

12 March 2013

Rwanda MR launch

Over 700 million children in 49 countries to be protected against measles and rubella

Rwanda’s measles-rubella vaccination campaign is the beginning of an effort to vaccinate more than 700 million children under 15 years of age against two disabling and deadly diseases.

07 March 2013

Haiti_UNICEF_2011_Marco-Dormino_4x6.jpg

Stronger protection for women and girls' health starts today

International Women's Day 2013 marks the beginning of a dramatic shift in the health of women and girls. Starting this year, GAVI is supporting the poorest countries of the world to roll out two vaccines that will directly benefit women and girls: human papillomavirus (HPV) against cervical cancer and rubella against 'German measles'.

close icon

modal window here